IBRNvsIGIB
iShares Neuroscience and Healthcare ETF against iShares 5-10 Year Investment Grade Corporate Bond ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| IBRN | IGIB | |
|---|---|---|
| Expense ratio | 0.47% | 0.040% |
| Assets | $6640.17T | $18.6B |
| Net flow, 1 month | −$60K | +$479M |
| Net flow, 1 year | +$2M | +$3.5B |
| Return, YTD | +1.7% | -6.7% |
| Return, 1 year | +22.3% | -7.1% |
| Avg daily volume | 2K | 3.6M |
| Holdings | 54 | 2744 |
| Listed | Aug 23, 2022 | Jan 4, 2007 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS